Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatin-Reference-Cited by-同舟云学术

Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatin

Published:2014-01-17 Issue:6 Volume:54 Page:649-656
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Custodio Joseph M.¹,Wang Hui¹,Hao Jia¹,Lepist Eve-Irene¹,Ray Adrian S.¹,Andrews Jessica¹,Ling Kah Hiing J.¹,Cheng Andrew¹,Kearney Brian P¹,Ramanathan Srinivasan¹

Affiliation:

1. Gilead Sciences, Inc.; Foster City CA USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference30 articles.

1. Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides;Dube;AIDS.,2005

2. Management of the metabolic effects of HIV and HIV drugs;Brown;Nat Rev Endocrinol.,2011

3. Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and coronary heart disease evaluation (Greace) study: a post-hoc analysis;Athyros;Lancet.,2010

4. Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors;Chauvin;Clin Pharmacokinet.,2013

5. 2013

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survey of Pharmaceutical Industry’s Best Practices around In Vitro Transporter Assessment and Implications for Drug Development: Considerations from the International Consortium for Innovation and Quality for Pharmaceutical Development Transporter Working Group;Drug Metabolism and Disposition;2024-05-02

2. Pathophysiology and Clinical Management of Dyslipidemia in People Living with HIV: Sailing through Rough Seas;Life;2024-03-28

3. Drug–drug interactions between COVID-19 therapeutics and antiretroviral treatment: the evidence to date;Expert Opinion on Drug Metabolism & Toxicology;2023-10-12

4. Achieving big with small: quantitative clinical pharmacology tools for drug development in pediatric rare diseases;Journal of Pharmacokinetics and Pharmacodynamics;2023-05-04

5. Statins in High Cardiovascular Risk Patients: Do Comorbidities and Characteristics Matter?;International Journal of Molecular Sciences;2022-08-18